Institut klinicke a experimentalni mediciny (IKEM)
Institut klinicke a experimentalni mediciny (IKEM)
Prague, Czechia1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR) | Antibody-mediated Rejection | Active, not recruiting | Phase 2 | 2026-07-02 | NCT06503731 |